{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:39:30Z","timestamp":1793147970629,"version":"4.5.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,5]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Is serum anti-M\u00fcllerian hormone (AMH) level predictive of cumulative live birth (CLB) rate after ART or in women trying to conceive naturally?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n Serum AMH level is linked to CLB after IVF\/ICSI but data are lacking after IUI or in women trying to conceive without ART.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Serum AMH level is a marker of ovarian reserve and a good predictor of ovarian response after controlled ovarian stimulation. It is unclear whether AMH measurement can predict CLB in spontaneous or assisted conception.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n A systematic review and meta-analysis was undertaken to assess whether serum AMH level may predict chances of CLB in infertile women undergoing IVF\/ICSI or IUI and\/or chances of live birth in women having conceived naturally.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n A systematic review and meta-analysis was performed using the following keywords: \u2018AMH\u2019, \u2018anti-mullerian hormone\u2019, \u2018live-birth\u2019, \u2018cumulative live birth\u2019. Searches were conducted from January 2004 to April 2021 on PubMed and Embase. Two independent reviewers carried out study selection, quality, and risk of bias assessment as well as data extraction. Odds ratios were estimated using a random-effect model. Pre-specified sensitivity analyses and subgroup analyses were performed. The primary outcome was CLB.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n A total of 32 studies were included in the meta-analysis. Overall, 27 articles were included in the meta-analysis of the relation between AMH and CLB or AMH and LB after IVF\/ICSI. A non-linear positive relation was found in both cases. A polynomial fraction was the best model to describe it but no discriminant AMH threshold was shown, especially no serum AMH level threshold below which live birth could not be achieved after IVF\/ICSI. After IVF\u2013ICSI, only four studies reported CLB rate according to AMH level. No statistically significant differences in mean serum AMH levels were shown between patients with and without CLB, but with a high heterogeneity. After exclusion of two studies with high risks of bias, there was no more heterogeneity [I2 = 0%] and the mean AMH level was statistically significantly higher in women with CLB. There were not enough articles\/data to assess the ability of AMH to predict CLB rate or find an AMH threshold after IUI or in women without history of infertility trying to conceive without ART.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n The systematic review and meta-analysis had some limitations owing to the limits and bias of the studies included. In the present meta-analysis, heterogeneity may have been caused by different baseline characteristics in study participants, different stimulating protocols for ART, different serum AMH level thresholds used and the use of various assays for serum AMH. This could explain, in part, the absence of a discriminating AMH threshold found in this analysis.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Serum AMH level is linked to CLB rate after IVF\/ICSI but no discriminating threshold can be established, therefore low serum AMH level should not be used as the sole criterion for rejecting IVF treatment, especially in young patients. Data are lacking concerning its predictive value after IUI or in women trying to conceive without ART. Our findings may be helpful to counsel candidate couples to IVF-ICSI.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTERESTS<\/jats:title>\n No external funding was obtained for this study. There are no conflicts of interest.<\/jats:p>\n <\/jats:sec>\n \n REGISTRATION NUMBER<\/jats:title>\n PROSPERO CRD42021269332.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/dead147","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T05:13:03Z","timestamp":1689916383000},"page":"1789-1806","source":"Crossref","is-referenced-by-count":36,"title":["Using serum anti-M\u00fcllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9987-0740","authenticated-orcid":false,"given":"Maeliss","family":"Peign\u00e9","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine and Fertility Preservation, AP-HP- H\u00f4pital Jean Verdier -Universit\u00e9 Sorbonne Paris Nord , Bondy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Reproductive Medicine, Centre Ali\u00e9nor d\u2019Aquitaine, Bordeaux University Hospital , Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dijols","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Fertility Preservation, H\u00f4pital Bretonneau, CHU de Tours , Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Creux","sequence":"additional","affiliation":[{"name":"Department of Gynecology-Obstetric and Reproductive Medicine, Clinique Saint Roch , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3185","authenticated-orcid":false,"given":"Geoffroy","family":"Robin","sequence":"additional","affiliation":[{"name":"CHU Lille, Assistance M\u00e9dicale \u00e0 la Procr\u00e9ation et Pr\u00e9servation de la Fertilit\u00e9 and UF de Gyn\u00e9cologie Endocrinienne\u2014Service de Gyn\u00e9cologie M\u00e9dicale, Orthog\u00e9nie et Sexologie, H\u00f4pital Jeanne de Flandre , Lille, France"},{"name":"Faculty of Medicine Henri Warembourg, University of Lille , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Hock\u00e9","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Reproductive Medicine, Centre Ali\u00e9nor d\u2019Aquitaine, Bordeaux University Hospital , Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-1802","authenticated-orcid":false,"given":"Micha\u00ebl","family":"Grynberg","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Fertility Preservation, AP-HP- H\u00f4pital Jean Verdier -Universit\u00e9 Sorbonne Paris Nord , Bondy, France"},{"name":"Department of Reproductive Medicine and Fertility Preservation, Universit\u00e9 Paris-Saclay, Assistance Publique H\u00f4pitaux de Paris, Antoine Becl\u00e8re Hospital , Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8521-5163","authenticated-orcid":false,"given":"Didier","family":"Dewailly","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Henri Warembourg, University of Lille , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-1592","authenticated-orcid":false,"given":"Charlotte","family":"Sonigo","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Fertility Preservation, Universit\u00e9 Paris-Saclay, Assistance Publique H\u00f4pitaux de Paris, Antoine Becl\u00e8re Hospital , Clamart, France"},{"name":"Universit\u00e9 Paris Saclay, Inserm, Physiologie et Physiopathologie Endocrinienne , Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023090508451217200_dead147-B1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2017.01.012","article-title":"A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF\/ICSI cycles","volume":"34","author":"Allegra","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","article-title":"Anti-M\u00fcllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-M\u00fcllerian hormone is modest","volume":"225","author":"Alson","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/09513590.2017.1399692","article-title":"The influence of age, body mass index, waist-to-hip ratio and anti-Mullerian hormone level on clinical pregnancy rates in ART","volume":"33","author":"Amsiejiene","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2023090508451217200_dead147-B4","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/01443615.2016.1225025","article-title":"Predictive values of anti-M\u00fcllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes","volume":"37","author":"Ashrafi","year":"2017","journal-title":"J Obstet Gynaecol"},{"key":"2023090508451217200_dead147-B6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array CGH analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"Ata","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?","volume":"31","author":"Bakas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2023090508451217200_dead147-B8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejogrb.2020.06.063","article-title":"Ovarian reserve as a predictor of cumulative live birth","volume":"252","author":"Balachandren","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2023090508451217200_dead147-B10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"2023090508451217200_dead147-B12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/09513590.2018.1465548","article-title":"Anti-M\u00fcllerian hormone levels and spontaneous pregnancy in women undergoing surgery for benign ovarian cysts","volume":"34","author":"Casadei","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2023090508451217200_dead147-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v072.c01","article-title":"Multivariate dose-response meta-analysis: the dosresmeta R package","volume":"72","author":"Crippa","year":"2016","journal-title":"J Stat Soft"},{"key":"2023090508451217200_dead147-B14","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1038\/s41598-020-76543-y","article-title":"AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles","volume":"10","author":"Dai","year":"2020","journal-title":"Sci Rep"},{"key":"2023090508451217200_dead147-B15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jogoh.2017.08.001","article-title":"What are the likely IVF\/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study","volume":"46","author":"Daney de Marcillac","year":"2017","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2023090508451217200_dead147-B16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/09513590.2017.1306848","article-title":"Anti-M\u00fcllerian hormone does not predict time to pregnancy: results of a prospective cohort study","volume":"33","author":"Depmann","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2023090508451217200_dead147-B17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2023090508451217200_dead147-B18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.fertnstert.2007.05.040","article-title":"Anti-M\u00fcllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients","volume":"89","author":"Elgindy","year":"2008","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/deab152","article-title":"Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients","volume":"36","author":"Esteves","year":"2021","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12884-020-03446-1","article-title":"Anti-M\u00fcllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study","volume":"20","author":"Ezoe","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2023090508451217200_dead147-B21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.rbmo.2018.12.032","article-title":"Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and\/or the need for additional preventive interventions: cumulative data over three stimulation cycles","volume":"38","author":"Fern\u00e1ndez-S\u00e1nchez","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.rbmo.2010.02.007","article-title":"Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study","volume":"20","author":"Freiesleben","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1479-828X.2011.01374.x","article-title":"Using anti-M\u00fcllerian hormone to identify a good prognosis group in women of advanced reproductive age","volume":"51","author":"Frid\u00e9n","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2023090508451217200_dead147-B25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","author":"van der Gaast","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B26","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher","year":"2010","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B27","first-page":"24","article-title":"Is AMH level, independent of age, a predictor of live birth in IVF?","volume":"10","author":"Goswami","year":"2017","journal-title":"J Hum Reprod Sci"},{"key":"2023090508451217200_dead147-B28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose\u2013response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am J Epidemiol"},{"key":"2023090508451217200_dead147-B29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12958-019-0452-4","article-title":"Prediction of the lower serum anti-M\u00fcllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys\u00ae AMH assay: a prospective observational study","volume":"17","author":"Grynnerup","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"2023090508451217200_dead147-B30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gyobfe.2012.02.001","article-title":"Low circulating anti-M\u00fcllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?","volume":"40","author":"Grzegorczyk-Martin","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"2023090508451217200_dead147-B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13048-021-00863-4","article-title":"Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients","volume":"14","author":"Guo","year":"2021","journal-title":"J Ovarian Res"},{"key":"2023090508451217200_dead147-B32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.fertnstert.2012.08.008","article-title":"Low concentration of circulating antim\u00fcllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study","volume":"98","author":"Hagen","year":"2012","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","article-title":"Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization","volume":"104","author":"Hamdine","year":"2015","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2022.10.014","article-title":"Markers of ovarian reserve as predictors of future fertility","volume":"119","author":"Harris","year":"2023","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"2023090508451217200_dead147-B36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-M\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2023090508451217200_dead147-B37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.rbmo.2021.01.023","article-title":"Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial","volume":"42","author":"Ishihara","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B38","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.fertnstert.2020.10.059","article-title":"Randomized, assessor-blind, antim\u00fcllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta","volume":"115","author":"Ishihara","year":"2021","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B39","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/humrep\/det303","article-title":"The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China","volume":"28","author":"Ji","year":"2013","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","article-title":"Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome","volume":"17","author":"Keane","year":"2017","journal-title":"Reprod Biol"},{"key":"2023090508451217200_dead147-B41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-6-3","article-title":"External validation of anti-M\u00fcllerian hormone based prediction of live birth in assisted conception","volume":"6","author":"Khader","year":"2013","journal-title":"J Ovarian Res"},{"key":"2023090508451217200_dead147-B42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5653\/cerm.2018.45.1.31","article-title":"The likelihood of achieving pregnancy through timed coitus in young infertile women with decreased ovarian reserve","volume":"45","author":"Koo","year":"2018","journal-title":"Clin Exp Reprod Med"},{"key":"2023090508451217200_dead147-B43","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1210\/jc.2011-1502","article-title":"Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls","volume":"96","author":"Kuiri-H\u00e4nninen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023090508451217200_dead147-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09513590.2015.1102879","article-title":"The use of ovarian reserve markers in IVF clinical practice: a national consensus","volume":"32","author":"La Marca","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2023090508451217200_dead147-B45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction","volume":"22","author":"La Marca","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"2023090508451217200_dead147-B47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jgyn.2011.08.005","article-title":"[Intra-uterine insemination outcomes according to the serum AMH level on day 3]","volume":"41","author":"Lamazou","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2023090508451217200_dead147-B48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1477-7827-7-100","article-title":"Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles","volume":"7","author":"Lee","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"2023090508451217200_dead147-B49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2017.12.047","article-title":"Predictive value of antral follicle count and serum anti-M\u00fcllerian hormone: which is better for live birth prediction in patients aged over 40 with their first IVF treatment?","volume":"221","author":"Lee","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B50","doi-asserted-by":"crossref","first-page":"e61095","DOI":"10.1371\/journal.pone.0061095","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"2023090508451217200_dead147-B51","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"Li","year":"2010","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B52","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2023090508451217200_dead147-B53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-M\u00fcllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"Lie Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fertnstert.2019.03.022","article-title":"Low antim\u00fcllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant","volume":"112","author":"Ligon","year":"2019","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B55","first-page":"6245","article-title":"Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF\/ICSI cycle","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"2023090508451217200_dead147-B56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10815-013-9973-5","article-title":"The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET)","volume":"30","author":"Lin","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2023090508451217200_dead147-B109","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1016\/j.csda.2009.05.001","article-title":"A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose\u2013response data","volume":"53","author":"Liu","year":"2009","journal-title":"Comput Stat Data Anal"},{"key":"2023090508451217200_dead147-B57","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jog.14269","article-title":"Anti-M\u00fcllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4","volume":"46","author":"Liu","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"2023090508451217200_dead147-B58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2013.01.013","article-title":"Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization","volume":"168","author":"Lukaszuk","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","article-title":"Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology","volume":"14","author":"Lukaszuk","year":"2014","journal-title":"Reprod Biol"},{"key":"2023090508451217200_dead147-B60"},{"key":"2023090508451217200_dead147-B61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B62","first-page":"356","article-title":"Live birth rate following intrauterine insemination in women with low or very low level of serum anti-M\u00fcllerian hormone","volume":"27","author":"Mehrafza","year":"2020","journal-title":"J Kerman Univ Med Sci"},{"key":"2023090508451217200_dead147-B63","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2023090508451217200_dead147-B64","first-page":"402","article-title":"Can we predict the IVF\/ICSI live birth rate?","volume":"4","author":"Metello","year":"2019","journal-title":"J JBRA Assist Reprod"},{"key":"2023090508451217200_dead147-B65","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1016\/j.eurox.2019.100043","article-title":"Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination","volume":"3","author":"Moreau","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"2023090508451217200_dead147-B66","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"Morin","year":"2018","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-11-61","article-title":"Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility","volume":"11","author":"Murto","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"2023090508451217200_dead147-B68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40738-019-0054-z","article-title":"Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss","volume":"5","author":"Murugappan","year":"2019","journal-title":"Fertil Res Pract"},{"key":"2023090508451217200_dead147-B69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","article-title":"Antral follicle count determines poor ovarian response better than anti-M\u00fcllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles","volume":"30","author":"Mutlu","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2023090508451217200_dead147-B70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.fertnstert.2015.04.032","article-title":"Antim\u00fcllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B71","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2013implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B73","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.rbmo.2020.12.001","article-title":"The risk of poor ovarian response during repeat IVF","volume":"42","author":"Papathanasiou","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2217\/whe.15.102","article-title":"Is anti-M\u00fcllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?","volume":"12","author":"Pereira","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"2023090508451217200_dead147-B75","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humrep\/deaa008","article-title":"Low anti-M\u00fcllerian hormone level is not a risk factor for early pregnancy loss in IVF\/ICSI treatment","volume":"35","author":"Peuranp\u00e4\u00e4","year":"2020","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B76","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023090508451217200_dead147-B77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-018-4946-7","article-title":"Does anti-Mullerian hormone predict the outcome of further pregnancies in idiopathic recurrent miscarriage? A retrospective cohort study","volume":"299","author":"Pils","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"2023090508451217200_dead147-B78","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.rbmo.2021.03.006","article-title":"Serum anti-M\u00fcllerian hormone levels are not associated with aneuploidy rates in human blastocysts","volume":"42","author":"Pipari","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.rbmo.2019.04.011","article-title":"Live birth rates remain stable in modified natural IVF despite low anti-M\u00fcllerian hormone: analysis of 638 cycles","volume":"39","author":"Preaubert","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B80","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"Qiao","year":"2021","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12967-019-2062-5","article-title":"Personalized prediction of live birth prior to the first in vitro fertilization treatment: a machine learning method","volume":"17","author":"Qiu","year":"2019","journal-title":"J Transl Med"},{"key":"2023090508451217200_dead147-B82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2016.02.007","article-title":"The value of Anti-M\u00fcllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization","volume":"200","author":"Reijnders","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023090508451217200_dead147-B83","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s10815-014-0289-x","article-title":"Serum antim\u00fcllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization","volume":"31","author":"Rezende","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2023090508451217200_dead147-B84","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.ajog.2008.05.004","article-title":"Assessment of ovarian reserve with anti-M\u00fcllerian hormone: a comparison of the predictive value of anti-M\u00fcllerian hormone, follicle-stimulating hormone, inhibin B, and age","volume":"199","author":"Riggs","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2023090508451217200_dead147-B85","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5468\/ogs.20168","article-title":"Association between decreased ovarian reserve and poor oocyte quality","volume":"64","author":"Scantamburlo","year":"2021","journal-title":"Obstet Gynecol Sci"},{"key":"2023090508451217200_dead147-B86","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/JCMA.0000000000000023","article-title":"The role of anti-M\u00fcllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination","volume":"82","author":"Seckin","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"2023090508451217200_dead147-B87","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2015.10.004","article-title":"Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antim\u00fcllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"105","author":"Seifer","year":"2016","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B88","doi-asserted-by":"crossref","first-page":"e2019006","DOI":"10.4178\/epih.e2019006","article-title":"Dose-response meta-analysis: application and practice using the R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"key":"2023090508451217200_dead147-B89","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/01443615.2013.810199","article-title":"Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds","volume":"33","author":"Speyer","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"2023090508451217200_dead147-B90","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2017.14588","article-title":"Association between biomarkers of ovarian reserve and infertility among older women of reproductive age","volume":"318","author":"Steiner","year":"2017","journal-title":"JAMA"},{"key":"2023090508451217200_dead147-B91","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.fertnstert.2016.12.013","article-title":"Does preoperative antim\u00fcllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?","volume":"107","author":"Stochino-Loi","year":"2017","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B92","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2013.10.007","article-title":"AMH concentration is not related to effective time to pregnancy in women who conceive naturally","volume":"28","author":"Streuli","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B93","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"2023090508451217200_dead147-B94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.29252\/ijrm.16.8.483","article-title":"Serum anti-Mullerian hormone and embryo morphokinetics detecting by time-lapse imaging: a comparison between the polycystic ovarian syndrome and tubal factor infertility","volume":"16","author":"Tabibnejad","year":"2018","journal-title":"IJRM"},{"key":"2023090508451217200_dead147-B95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2023090508451217200_dead147-B96","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/clinem\/dgab168","article-title":"AMH highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age","volume":"106","author":"Tal","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2023090508451217200_dead147-B97","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antim\u00fcllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B99","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2019.12.006","article-title":"Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve","volume":"113","author":"Tiegs","year":"2020","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1479-828X.2010.01232.x","article-title":"Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy","volume":"50","author":"Tremellen","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2023090508451217200_dead147-B101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"2023090508451217200_dead147-B102","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.rbmo.2010.06.041","article-title":"The association between anti-M\u00fcllerian hormone and IVF pregnancy outcomes is influenced by age","volume":"21","author":"Wang","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2023090508451217200_dead147-B103","doi-asserted-by":"crossref","first-page":"hoaa049","DOI":"10.1093\/hropen\/hoaa049","article-title":"The ovarian sensitivity index is predictive of live birth chances after IVF in infertile patients","volume":"2020","author":"Weghofer","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2023090508451217200_dead147-B104","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00404-018-5034-8","article-title":"Only women\u2019s age and the duration of infertility are the prognostic factors for the success rate of natural cycle IVF","volume":"299","author":"von Wolff","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"2023090508451217200_dead147-B105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.fertnstert.2013.05.009","article-title":"Antim\u00fcllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study","volume":"100","author":"Yarde","year":"2013","journal-title":"Fertil Steril"},{"key":"2023090508451217200_dead147-B106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43043-019-0014-x","article-title":"Live birth rate after IVF\/ICSI in women with low and extremely low AMH: an age-matched controlled study","volume":"25","author":"Zaghloul","year":"2020","journal-title":"Middle East Fertil Soc J"},{"key":"2023090508451217200_dead147-B107","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2015-2474","article-title":"Is anti-M\u00fcllerian hormone associated with fecundability? Findings from the EAGeR trial","volume":"100","author":"Zarek","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2023090508451217200_dead147-B108","doi-asserted-by":"crossref","first-page":"e6495","DOI":"10.1097\/MD.0000000000006495","article-title":"Ovarian response prediction in controlled ovarian stimulation for IVF using anti-M\u00fcllerian hormone in Chinese women: a retrospective cohort study","volume":"96","author":"Zheng","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/9\/1789\/51345440\/dead147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/9\/1789\/51345440\/dead147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:50:03Z","timestamp":1693903803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/9\/1789\/7227289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":109,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,20]]},"published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead147","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,7,20]]}}}